EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 5.90% over 3 years and 1.83% over 5 years; the trailing 12 months came in at +121.20%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
British American Tobacco p.l.c. (BTI)
EBITDA growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
Reported quarterly EBITDA; no daily interpolation. Q2 FY2026 (2026-06-30): $8.07B.
Current FMP quote-based enterprise value / operating income plus matched D&A from the trailing two half-years (the two consecutive half-year periods ended 2025-12-31 and 2026-06-30) Quote observation: 2026-10-06T09:00:32.249Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2009-06-30.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $7.30B | $16.15B | +$8.84B | +121.08% |
| 2024 | $13.59B | $7.30B | −$6.29B | -46.27% |
| 2022 | $15.13B | $13.59B | −$1.54B | -10.18% |
| 2021 | $14.74B | $15.13B | +$390.05M | +2.65% |
| 2020 | $15.03B | $14.74B | −$287.90M | -1.92% |
| 2019 | $14.04B | $15.03B | +$989.99M | +7.05% |
| 2018 | $10.78B | $14.04B | +$3.26B | +30.20% |
| 2017 | $7.15B | $10.78B | +$3.63B | +50.82% |
| 2016 | $7.86B | $7.15B | −$711.42M | -9.05% |
| 2015 | $8.50B | $7.86B | −$640.81M | -7.54% |
| 2014 | $10.23B | $8.50B | −$1.73B | -16.88% |
| 2013 | $9.57B | $10.23B | +$655.67M | +6.85% |
| 2012 | $8.61B | $9.57B | +$964.81M | +11.21% |
| 2011 | $8.13B | $8.61B | +$475.99M | +5.85% |
| 2010 | $7.62B | $8.13B | +$516.58M | +6.78% |
| 2009 | $5.82B | $7.62B | +$1.80B | +30.87% |
| 2008 | $6.43B | $5.82B | −$607.64M | -9.45% |
| 2007 | $5.83B | $6.43B | +$602.30M | +10.34% |
| 2006 | $4.82B | $5.83B | +$1.00B | +20.79% |
| 2005 | $7.92B | $4.82B | −$3.10B | -39.13% |
| 2004 | $4.88B | $7.92B | +$3.05B | +62.44% |
| 2003 | $547.72M | $4.88B | +$4.33B | +790.40% |
| 2002 | $3.74B | $547.72M | −$3.19B | -85.36% |
| 2001 | $3.26B | $3.74B | +$478.37M | +14.66% |
| 2000 | $2.95B | $3.26B | +$309.39M | +10.48% |
| 1999 | $2.18B | $2.95B | +$777.74M | +35.75% |
| 1998 | $2.55B | $2.18B | −$372.27M | -14.61% |
| 1997 | $3.33B | $2.55B | −$783.01M | -23.51% |
| Period | Period End | Value | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Q2 FY2026 | 2026-06-30 | $8.07B | N/A | N/A |
| Q4 FY2025 | 2025-12-31 | $7.93B | N/A | N/A |
| Q2 FY2025 | 2025-06-30 | $8.50B | N/A | N/A |
| Q4 FY2024 | 2024-12-31 | -$51.30M | N/A | N/A |
| Q2 FY2024 | 2024-06-30 | $7.43B | N/A | N/A |
| Q4 FY2023 | 2023-12-31 | -$27.40B | N/A |
| N/A |
| Q2 FY2023 | 2023-06-30 | $8.14B | N/A | N/A |
| Q4 FY2022 | 2022-12-31 | $8.51B | N/A | N/A |
| Q2 FY2022 | 2022-06-30 | $5.12B | N/A | N/A |
| Q4 FY2021 | 2021-12-31 | $8.78B | N/A | N/A |
| Q2 FY2021 | 2021-06-30 | $7.66B | N/A | N/A |
| Q4 FY2020 | 2020-12-31 | $8.80B | N/A | N/A |
| Q2 FY2020 | 2020-06-30 | $7.06B | N/A | N/A |
| Q4 FY2019 | 2019-12-31 | $8.97B | N/A | N/A |
| Q2 FY2019 | 2019-06-30 | $6.46B | N/A | N/A |
| Q4 FY2018 | 2018-12-31 | $7.40B | N/A | N/A |
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.
